Similar Papers

Paper Title
Journal
Date
Author
Real-World data (RWD) of physician’s advice on BRCA genetic testing for ovary (OC) and breast cancer (BC) patients (pts).
Daniel A. Vorobiof
Journal of Clinical Oncology | VOL. 38
Daniel A. VorobiofDaniel A. Vorobiof
20 May 2020
BRCA reversion mutations mediated by microhomology-mediated end joining (MMEJ) as a mechanism of resistance to PARP inhibitors in ovarian and breast cancer.
Natalia Lukashchuk ... Luis Tobalina
Journal of Clinical Oncology | VOL. 40
Natalia Lukashchuk, et. al.Natalia Lukashchuk ... Luis Tobalina
01 Jun 2022
Racial/ethnic differences in telemedicine utilization and satisfaction among patients with breast cancer during the COVID-19 pandemic.
Jincong Freeman ... Rita Nanda
Journal of Clinical Oncology | VOL. 40
Jincong Freeman, et. al.Jincong Freeman ... Rita Nanda
01 Oct 2022
Prognostic value of early treatment response in children with acute myeloid leukemia
Li-Jun Tie ... Jia-Yin Zou
National Medical Journal of China | VOL. 86
Li-Jun Tie, et. al.Li-Jun Tie ... Jia-Yin Zou
11 Jul 2006
View more papers

More From: Cancer Research

Paper Title
Journal
Date
Author
Editor's Note: Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo.
Flaminia Talos ... Ute M Moll
Cancer research | VOL. 85
Flaminia Talos, et. al.Flaminia Talos ... Ute M Moll
15 Jan 2025
Correction: Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy.
Kit Gallagher ... Alexander R A Anderson
Cancer research | VOL. 85
Kit Gallagher, et. al.Kit Gallagher ... Alexander R A Anderson
15 Jan 2025
Transcription Factor Fingerprint Provides Clues for Brain Tumor Cell of Origin.
Brent A Orr
Cancer research | VOL. 85
Brent A OrrBrent A Orr
15 Jan 2025
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response.
Erik Blomain ... Everett J Moding
Cancer research | VOL. -
Erik Blomain, et. al.Erik Blomain ... Everett J Moding
14 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.